Tertiary lymphoid structures in head and neck squamous cell carcinoma (Review)
- PMID: 40341409
- DOI: 10.3892/or.2025.8909
Tertiary lymphoid structures in head and neck squamous cell carcinoma (Review)
Abstract
The tumor microenvironment in head and neck squamous cell carcinoma (HNSCC) has a critical role in tumor progression and prognosis. The organization of T cells, B cells and high‑endothelial venules into structures termed tertiary lymphoid structures (TLS), are associated with favorable outcomes in HNSCC. Despite their importance, the formation and function of TLS‑associated immune cells in HNSCC have remained elusive. The aim of the present review is to elucidate the mechanism underlying TLS formation, which may contribute to the development of novel and effective immunotherapies for HNSCC, and summarize recent advances in HNSCC treatment.
Keywords: cellular immune response; head and neck squamous cell carcinoma; immunotherapy; oral squamous cell carcinoma; tertiary lymphoid structures; tumor microenvironment.
Similar articles
-
Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes.Cancer Immunol Immunother. 2025 Feb 11;74(3):107. doi: 10.1007/s00262-025-03952-1. Cancer Immunol Immunother. 2025. PMID: 39932546 Free PMC article.
-
A novel tertiary lymphoid structure-associated signature accurately predicts patient prognosis and facilitates the selection of personalized treatment strategies for HNSCC.Front Immunol. 2025 Mar 13;16:1551844. doi: 10.3389/fimmu.2025.1551844. eCollection 2025. Front Immunol. 2025. PMID: 40181975 Free PMC article.
-
Tertiary lymphoid structure-related score as a predictor for survival prognosis and immunotherapy response in head and neck squamous cell carcinoma.Front Immunol. 2024 Oct 18;15:1483497. doi: 10.3389/fimmu.2024.1483497. eCollection 2024. Front Immunol. 2024. PMID: 39493749 Free PMC article.
-
Unraveling the immune evasion mechanisms in the tumor microenvironment of head and neck squamous cell carcinoma.Front Immunol. 2025 May 14;16:1597202. doi: 10.3389/fimmu.2025.1597202. eCollection 2025. Front Immunol. 2025. PMID: 40438103 Free PMC article. Review.
-
Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma.Front Immunol. 2025 Jan 2;15:1522820. doi: 10.3389/fimmu.2024.1522820. eCollection 2024. Front Immunol. 2025. PMID: 39830511 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical